SCHEMBL7658018

SCHEMBL7658018

Cc1[nH]c2ccc(NC(=O)c3cccc4ccccc34)cc2c1CCN(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 2/20 0.64
HTR6 P50406 4/20 0.52
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
STK17B O94768 1/20 0.49
STK17A Q9UEE5 1/20 0.49
HTR7 P34969 3/20 0.48
HTR2B P41595 2/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
HTR1A P08908 2/20 0.47
HTR1D P28221 2/20 0.47
SLC6A2 P23975 1/20 0.47
HTR1E P28566 1/20 0.47
HTR5A P47898 1/20 0.47
DEGS1 O15121 1/20 0.46
NR1H4 Q96RI1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7655272 0.89 HTR1F (0.68) HTR1FHTR6MEN1KMT2ANPC1
SCHEMBL7142178 0.87 HTR1F (0.71) HTR1FHTR6MEN1KMT2ANPC1
SCHEMBL7143345 0.85 HTR1F (0.63) HTR1FHTR6MEN1KMT2ANPC1
SCHEMBL7146860 0.85 HTR1F (0.69) HTR1FHTR6MEN1KMT2ASTK17B
SCHEMBL7140880 0.84 HTR1F (0.65) HTR1FHTR6STK17BSTK17AHTR7
SCHEMBL7138192 0.84 HTR1F (0.80) HTR1FHTR6MEN1KMT2ANPC1
SCHEMBL7146433 0.84 HTR1F (0.73) HTR1FHTR6MEN1KMT2ANPC1
SCHEMBL7140329 0.82 HTR1F (0.62) HTR1FHTR6MEN1KMT2ANPC1
SCHEMBL7146383 0.82 HTR1F (0.73) HTR1FHTR6MEN1KMT2ANPC1
SCHEMBL7147525 0.82 HTR1F (0.67) HTR1FHTR6MEN1KMT2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed